Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that patient dosing is now ...

Lunsumio Velo is supplied as a ready-to-use, preservative-free solution in single-dose vials containing 5mg/0.5mL and 45mg/mL.

The Phase 1b/2 SCLC trial and Phase 2 VIRO-25 trial are actively enrolling in dose escalation cohorts with an aim to optimize efficacy, safety, and tolerability of Olvi-Vec. The trials are being ...

Panelists discuss how shared decision-making empowers patients when choosing between IV and SC administration routes. Panelists discuss how patient counseling and shared decision-making are central to ...

IV therapy for weight loss involves administering vitamins, minerals, or medications directly into your vein. There are no official guidelines for its use in weight loss, and very limited research ...

In late September, Hurricane Helene damaged a major supplier of intravenous (IV) fluids. In this report, we follow up on what has happened since. Hurricane Helene brought unprecedented and ...

This is a MedPage Today story. In late September, Hurricane Helene damaged a major supplier of intravenous (IV) fluids. In this report, we follow up on what has happened since. Hurricane Helene ...

The Administration for Strategic Preparedness and Response has partnered with SLI Medical to ship 41,000 cases of IV fluids to the U.S. to help mitigate an ongoing shortage exacerbated by disruptions ...

Last month, nearly 60% of hospitals nationally reported concerns they would have to postpone shortages due to the IV shortages, with 17% saying they already taken that step. UR Medicine delayed ...